Central Europe Online : Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Central Europe Online .

Press releases published on June 1, 2026

Jun. 1, 2026

ABB expands collaboration with NVIDIA through integration of DSX Blueprint for AI infrastructure

Indeterminate GlobeNewswire

Jun. 1, 2026

Orano Increases Ownership in Cigar Lake Mine in Canada

Indeterminate GlobeNewswire

Jun. 1, 2026

AMAX Accelerates AI Factory Performance with New Intel Xeon 6+ Processors

Indeterminate EIN Presswire

Jun. 1, 2026

Zealand Pharma - Transactions related to share buy-back program (week 22, 2026)

Indeterminate GlobeNewswire

Jun. 1, 2026

Virtune AB (Publ) („Virtune“) hat die Neugewichtung für Mai 2026 des Virtune Coinbase 50 Index ETP durchgeführt

Indeterminate GlobeNewswire

Jun. 1, 2026

Virtune AB (Publ) ("Virtune") has completed the rebalancing for May 2026 of its Virtune Coinbase 50 Index ETP

Indeterminate GlobeNewswire

Jun. 1, 2026

Virtune AB (Publ) (“Virtune”) har genomfört rebalanseringen för maj 2026 av Virtune Coinbase 50 Index ETP

Indeterminate GlobeNewswire

Jun. 1, 2026

Digital ATA Carnets Live Today Across UK, EU, Norway and Switzerland

Indeterminate GlobeNewswire

Jun. 1, 2026

Strativerse.Ai Launches AI Solution for Automated Strategy Development

Indeterminate GlobeNewswire

Jun. 1, 2026

INEX Club Charity Ride 2026 Finishes Strong in Cyprus, Raising Support for Young Cyclists

Indeterminate GlobeNewswire

Jun. 1, 2026

Introducing Evosep Proteomics to Standardize and Scale Proteomics for Research and Drug Development

Indeterminate GlobeNewswire

Jun. 1, 2026

Ardena appoints Ariane de Ganck as Chief Scientific Officer

Indeterminate GlobeNewswire

Jun. 1, 2026

Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches

Indeterminate GlobeNewswire

Jun. 1, 2026

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

Indeterminate GlobeNewswire

Jun. 1, 2026

ADEX Investigation Reveals XCSSET Supply-Chain Threat Hidden in Xcode Build Files

Indeterminate GlobeNewswire

Jun. 1, 2026

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

Indeterminate GlobeNewswire

Jun. 1, 2026

Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

Jun. 1, 2026

Rezolve Ai Positioned at the Heart of the AI Transformation of $30 Trillion Global Retail, Reiterates $360M+ FY26 Revenue Guidance

Indeterminate GlobeNewswire

Jun. 1, 2026

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Indeterminate GlobeNewswire